Company intelligence / Profile preview

PharmIdea

Olaine, Olaine district, Latviapharmidea.lv ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

PharmIdea is a GMP-certified pharmaceutical company specializing in sterile drug development and manufacturing with over 15 years of experience. It produces generic injectable drugs across multiple therapeutic areas including oncology and women’s health. The company supplies products to more than 60 countries worldwide[1][4]. Its product range includes commercialized generics such as bortezomib and caspofungin.

Therapeutic areas: OncologyCardiovascularInfectious DiseasesWomen's Health
Modalities: Small moleculePeptides
Industry: Biotech

Partnerships

Latvijas Organiskās sintēzes institūtsSelectchemie AGLogenex Pharm GmbHViet PhapAustell Laboratories Ltd.Kuwait Saudi Pharmaceutical Industries Co.AV Medical CZ s.r.o.Polfa SA TarchominLIDDS AB

Beyond the preview

Go deeper on PharmIdea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmIdea.

Explore the full profile